Bioresorbable Stent in Anterior Cruciate Ligament Reconstruction

Area of Science:

• Orthopedic surgery
• Biomaterials science
• Regenerative medicine

Background:

• Anterior cruciate ligament (ACL) reconstruction failure is often linked to bone tunnel enlargement (BTE).
• Preventing BTE is crucial for successful ACL reconstruction outcomes.
• Polylactide (PLA) possesses osteogenic and osteoconductive properties beneficial for bone healing.

Purpose of the Study:

• To evaluate the efficacy of a bioresorbable polylactide (PLA) stent in preventing bone tunnel enlargement (BTE) after ACL reconstruction.
• To assess the impact of PLA stent implantation on bone microarchitecture adjacent to the tunnels.
• To determine if PLA can facilitate osteointegration of the tendon graft in ACL reconstruction.

Main Methods:

• ACL reconstruction was performed on 24 skeletally mature sheep.
• Animals were randomized into two groups: PLA stent implantation (n=16) and control (n=8).
• Knee joints were analyzed using X-ray microcomputed tomography (50 μm resolution) at 6 and 12 weeks post-surgery.

Main Results:

• Bone tunnel enlargement (BTE) was observed in both groups, but was significantly less pronounced in the PLA stent group.
• Microstructural analysis indicated improved bone quality adjacent to the tunnels in the PLA group.
• The PLA stent demonstrated a potential to mitigate BTE and enhance bone integration.

Conclusions:

• Implantation of a bioresorbable PLA stent may reduce bone tunnel enlargement following ACL reconstruction.
• PLA stents show promise in facilitating osteointegration of tendon grafts, potentially improving ACL reconstruction success.
• The osteogenic and osteoconductive properties of PLA likely contribute to its beneficial effects.